ISSUE 99 I OCTOBER 2020

under the

microscope

As factory inspections resume, what can manufacturers do to ensure they are up to scratch?

Oxytocin: Could love be a drug?

AI-enabled risk detection

Disrupting the fertility sector

02/24/2024 02:40:08

09/23/2020 00:00:00

Go to article: Home | Under the microscope Go to article: In this issue Go to article: SHL Medical Company Insight Go to article: SHL Medical Go to article: Contents Go to article: Mimotopes Go to article: News Go to article: VEGA Australia Go to article: Covid-19 executive briefing by GlobalData Go to article: Wipotec Go to article: Nasal spray vaccine for Covid-19 Go to article: Datwyler Company Insight Go to article: Datwyler Go to article: Covid-19 clinical trials continue to rise in Brazil Go to article: Biogazelle Go to article: AstraZeneca’s Phase I / II Covid-19 vaccine trial Go to article: Swiftpak Go to article: MTPA resumes screening and enrolment for global Phase III clinical trial of MT-1 Go to article: Biesterfeld Go to article: The pharma industry briefing Go to article: From antitoxins to Covid-19 drugs: charting the history of antibody drugs Go to article: Quality control: pharma manufacturing inspections explained Go to article: Molnár-Institute Company Insight Go to article: Molnar-Institute Go to article: Oxytocin: the therapeutic potential of the ‘love hormone’Go to article: AI-enabled risk detection in pharma manufacturing Go to article: Dr. Paul Lohmann Go to article: Addressing the long-term effects of Covid-19 Go to article: Eyes on the prize: the latest in retinitis pigmentosa gene therapies Go to article: HOF Sonderanlagenbau Company Insight Go to article: HOF Sonderanlagenbau Go to article: Breaking the taboo: disrupting the fertility sector Go to article: Neutralising the gluten threat: are we on the cusp of a coeliac disease breakthrough? Go to article: Nolato Company Insight Go to article: Nolato Go to article: Pharmacovigilance case intake: why the hesitation to automate?Go to article: Deals in brief powered by GlobalData Go to article: The key list powered by GlobalData Go to article: Zenatek Go to article: Global markets and indices powered by GlobalData Go to article: Macro-economic indicators (1 of 2) powered by GlobalData Go to article: Macro-economic indicators (2 of 2) powered by GlobalData Go to article: Events Go to article: Next issue